Search
Menu
Home
HTB
2001
May
HTB
May 2001
Contents
Conference reports
2nd International workshop on Clinical Pharmacology of HIV Therapy, 2-4 April, Noordwijk, The Netherlands
First randomised trial shows clinical benefit of TDM for people using nelfinavir or indinavir containing combinations
Clinical Pharmacology of Antiretroviral Therapy, Liverpool, UK , March 2001
Antiretrovirals
Outcome of patients with discordant responses to HAART
Self-reported symptoms after starting HAART help predict adherence
DuPont applies to FDA for approval of one-tablet, once daily formulation of efavirenz
Patient age influences CD4+ cell recovery with HAART
Preliminary data from four studies of double PI regimen using once daily Fortovase plus “mini dose” ritonavir
Treatment access
Drug companies withdraw HIV drug lawsuit against South Africa
Ethiopia to import AIDS drugs for first time
AIDS care for Africa affordable
Tony Blair sides with drug giants
Women's health
HAART lowers CIN recurrence risk in HIV-positive women
Paediatric care
Antiretroviral therapy improves measles vaccination response in HIV-infected children
Coinfections and complications
Cancer risk increased with AIDS
Cancer and HIV
HIV status predicts anal dysphasia and carcinoma risk in HPV-infected individuals
Anal neoplasia grade linked with genetic changes
Hepatitis coinfection
HIV/HCV coinfection: amid swirling controversy the profile of a killer emerges
French study finds low death rate due to hepatitis C virus in HIV-positive patients
TB coinfection
Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection
Drug resistance
Drug resistant HIV spreading in UK
Other news
Company lobbyist joins Oxfam campaign for cheaper HIV drugs
John Le Carre describes drug industry’s ‘crimes of unbridled capitalism’ in Nation column
College students protest university patents on AIDS drugs
IAPAC to launch HIV training, certification program for developing world physicians
South African panel recognizes HIV as cause of AIDS
PDFs
Volume 2 Number 4 May 2001 PDF
HTB RSS
Early access
Lenacapavir submitted to the US FDA with an indication for HIV PrEP
20 December 2024
i-Base guides updated online
5 December 2024
All early access reports
Current issues
December 2024
November 2024
October 2024
Back issues
Special report
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate